In vitro studies have shown that in bronchial epithelial cells, hyperglycemia increases HMGB1 while it is lowered by insulin (Montanini et al., 2016; Seidu et al., 2020), suggesting that this protein might be a vulnerability marker besides a therapeutic target. This evidence concerns the gene HMGB1 and Hyperglycemia.